e.g. mhealth
Search Results (1 to 4 of 4 Results)
Download search results: CSV END BibTex RIS
Skip search results from other journals and go to results- 2 Interactive Journal of Medical Research
- 1 JMIR Formative Research
- 1 JMIR Research Protocols
- 0 Journal of Medical Internet Research
- 0 Medicine 2.0
- 0 iProceedings
- 0 JMIR Human Factors
- 0 JMIR Medical Informatics
- 0 JMIR Public Health and Surveillance
- 0 JMIR mHealth and uHealth
- 0 JMIR Serious Games
- 0 JMIR Mental Health
- 0 JMIR Rehabilitation and Assistive Technologies
- 0 JMIR Preprints
- 0 JMIR Bioinformatics and Biotechnology
- 0 JMIR Medical Education
- 0 JMIR Cancer
- 0 JMIR Challenges
- 0 JMIR Diabetes
- 0 JMIR Biomedical Engineering
- 0 JMIR Data
- 0 JMIR Cardio
- 0 Journal of Participatory Medicine
- 0 JMIR Dermatology
- 0 JMIR Pediatrics and Parenting
- 0 JMIR Aging
- 0 JMIR Perioperative Medicine
- 0 JMIR Nursing
- 0 JMIRx Med
- 0 JMIRx Bio
- 0 JMIR Infodemiology
- 0 Transfer Hub (manuscript eXchange)
- 0 JMIR AI
- 0 JMIR Neurotechnology
- 0 Asian/Pacific Island Nursing Journal
- 0 Online Journal of Public Health Informatics
- 0 JMIR XR and Spatial Computing (JMXR)
Cardiovascular Comorbidities in COVID-19: Comprehensive Analysis of Key Topics
Figure 5 C illustrates that within the realm of CVDs, “Embolism and Thrombosis” emerges as the most prevalent LV3 Me SH descriptor utilized in the literature, followed by “Hypertension” and “Heart Failure,” among others, in descending order of frequency.
By comparing Figure 5 B and 5 C, we observe a less diverse distribution of the embedded Me SH terms.
Interact J Med Res 2024;13:e55699
Download Citation: END BibTex RIS
Online Search Trends Influencing Anticoagulation in Patients With COVID-19: Observational Study
This was soon followed by marked increases in clinical thrombosis, including deep vein thromboses, pulmonary emboli [1,2], and microthrombi in pulmonary vasculature in postmortem pathological studies [3]. Clinical debate ensued surrounding the best strategy to prevent and treat COVID-19–associated coagulopathy. By the middle of April 2020, an international position paper recommended the provision of adequate thromboprophylaxis in hospitalized patients with COVID-19 [4].
JMIR Form Res 2021;5(8):e21817
Download Citation: END BibTex RIS
COVID-19 #StayAtHome Restrictions and Deep Vein Thrombosis: Case Report
An otherwise completely healthy 84-year-old woman was admitted to the hospital due to deep vein thrombosis (DVT) in mid-April 2020. She had no pre-existing conditions, she was not taking any medication, and she did not have any cardiovascular risk factors apart from her age. Before the COVID-19 pandemic, the patient was very mobile for her age; she regularly went out for shopping and walks with her husband, and was active in her church group.
Interact J Med Res 2021;10(1):e23443
Download Citation: END BibTex RIS
This will include (1) the assessment of aspirin prophylactic efficacy for all types of thrombotic events that patients with ESRD may develop, namely nonfatal stroke, nonfatal myocardial infarction, arteriovenous fistula thrombosis, and cardiac mortality, and (2) the assessment of aspirin-related major bleeding events using Thrombolysis in Myocardial Infarction (TIMI) criteria [17-19].
JMIR Res Protoc 2018;7(8):e10516
Download Citation: END BibTex RIS